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Abstract 
Hydrochlorothiazide is chemically 6-chloro-1, 1-dioxo-3, 4-dihydro-2H-1, 2, 4-benzothiadiazine-7-
sulfonamide. Hydrochlorothiazide is a diuretic drug used for treatment of high blood pressure (hypertension) 
and accumulation of fluid (edema). It works by blocking salt and fluid reabsorption from the urine in the 
kidneys, causing increased urine output (dieresis). Hydrochlorothiazide is used to treat excessive fluid 
accumulation and swelling (edema) of the body caused by heart failure, cirrhosis, chronic kidney failure, 
corticosteroid medications, and nephrotic syndrome. It can be used alone or in conjunction with other blood 
pressure lowering medications to treat high blood pressure.  
This review focuses on the recent developments in analytical techniques for estimation of 
Hydrochlorothiazide alone or in combinations with other drugs in various biological media like human plasma 
and urine. This review will critically examine the (a) sample pretreatment method such as solid phase extraction 
(SPE), (b) separation methods such as thin layer chromatography (TLC), high performance liquid 
chromatography (HPLC), ultra performance liquid chromatography (UPLC), high performance thin layer 
chromatography (HPTLC), liquid chromatography coupled to tandem mass spectrometry (LC-MS) and 
capillary electrophoresis (CE), (c) other methods such as spectrophotometry, diffuse reflectance near infrared 
spectroscopy and electrochemical methods. 
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1.  Introduction 
Hydrochlorothiazide is analogues of 1, 2, 4-
benzothiadiazine-1, 1-dioxide.  Hydrochlorothiazide 
diuretics are among the most commonly used 
antihypertensives and have been available for over 50 
years. Thiazides are preferred in hypertensive 
patients with osteoporosis. Secondary beneficial 
effect in hypertensive geriatric patients of reducing 
the risk of osteoporosis is the secondary to effect on 
calcium homeostasis and bone mineralization. 
Thiazide diuretics used in patients who are at an 
increased risk for developing hyperkalemia[1].  
Thiazides achieve their diuretic action via 
inhibition of the Na
+
/Cl
−
 cotransporter (NCC) in the 
renal distal convoluted tubule [2-4]. The NCC 
facilitates the absorption of sodium from the distal 
tubules back to the interstitium and accounts for 
approximately 7% of total sodium reabsorption [5]. 
By decreasing sodium reabsorption, thiazide use 
acutely results in an increase in fluid loss to urine, 
which leads to decreased extracellular fluid and 
plasma volume. This volume loss results in 
diminished venous return, increased renin release, 
reduced cardiac output and decreased blood 
pressure[6]. Within days, the reduction in cardiac 
output increases total peripheral resistance, which 
stems mostly from activation of the sympathetic 
nervous system and renin angiotensin aldosterone 
system [7,8]. This acute effect is evidenced by the 
fact that an infusion of dextran, a volume expander, 
during the acute thiazide treatment phase restores 
blood pressure to pretreatment levels [9]. 
Due to the importance of this class in 
treatment of hypertension, there is need to review the 
analytical work reported in the literature for 
estimation of Hydrochlorothiazide alone and with its 
combinations which would be very useful 
information for an academic and industrial 
prospective. 
 
 
2. Physical and Chemical Property 
Hydrochlorothiazide is white or almost 
white, crystalline powder. IUPAC name of 
Hydrochlorothiazide is 6-Chloro-3, 4-dihydro-2H-1, 
2, 4-benzothiadiazine-7-sulphonamide 1, 1-dioxide 
(Fig.1.). Chemical formula of Hydrochlorothiazide is 
C7H8ClN3O4S2. Molecular weight is 297.7 gm/mol. 
Very slightly soluble in water, soluble in acetone, 
sparingly soluble in ethanol (96%). It dissolves in 
dilute solutions of alkali hydroxides [10-13]. 
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Fig.1. Chemical Structure of Hydrochlorothiazide 
 
3. Analytical Methods 
Analytical method development and 
validation plays an important role in the discovery, 
development and manufacture of pharmaceuticals. 
The official test methods that result from these 
processes are used by quality control laboratories to 
ensure the identity, purity, potency and performance 
of drug products. After therapeutic administration of 
drug formulation, to check therapeutic concentration 
of drug in human body, there is a need for analytical 
methods. Analytical Methods are necessary for 
therapeutic drug monitoring. High Performance 
Liquid Chromatography (HPLC) together with 
various types of detection UV (ultraviolet), FD 
(fluorescence detection) and MS (mass spectrometry) 
has become the method of choice for analytical 
method development. Apart from these methods 
other analytical methods also used which are High 
performance thin layer chromatography [50-52], 
Ultra performance liquid chromatography [59,60], 
Thin layer chromatography [62], Voltammetry [16], 
Capillary electrophoresis are also widely used[14,15]. 
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3.1 Capillary electrophoresis method 
Hillaert et al[14] developed a capillary 
electrophoresis method for the simultaneous 
determination of Hydrochlorothiazide and several 
angiotensin-converting enzyme (ACE) inhibitors: 
enalapril, lisinopril, quinapril, fosinopril, ramipril, 
and cilazapril. The most critical parameter is the pH 
of the running buffer. Separation was performed on a 
fused-silica capillary (52 cm total length ×75 µm 
I.D.) using a sodium phosphate buffer (pH 7.25; 100 
mM). The method was successfully applied to the 
quantitative determination of these compounds in 
their corresponding pharmaceutical formulation. 
In another study, Alnajjar et al[15] 
developed a capillary electrophoresis method for the 
separation and quantification of metoprolol (MET) 
and Hydrochlorothiazide (HCT) in their combined 
dosage form. MET and HCT were detected at 240 
and 214 nm, respectively, using a photodiode array 
detector. The univariate approach was used for 
optimizing voltage, injection time and capillary 
temperature. The optimum conditions were 50 
mmol/L phosphate at pH 9.5, injection time 10.0 s, 
voltage 25 kV and capillary temperature 25C. The 
method was linear in the range of 2.5–250 mg/mL for 
both drugs with correlation coefficients above 
0.9997. Additionally, acceptable recovery of the 
contents of MET and HCTZ in their formulations 
(96.0– 100.3%) with acceptable precision (1.38–2.60 
%) were achieved. Moreover, the limits of detection 
of MET and HCTZ were 0.02 and 0.01 µg/mL, 
respectively, which were suitable for pharmaceutical 
analysis. 
3.2 Electrochemical method / Voltammetric 
method 
Voltametric method was developed by 
Razak[16] for hydrochlorothiazide at glassy carbon 
electrode was carried out. The drug in Britton–
Robinson buffer (pH 3.3) is oxidized at +1040 mV, 
giving rise to a well-defined peak. The procedure has 
been applied for the drug determination in human 
urine with no prior extraction and in commercial 
tablets. The proposed method has been validated. The 
limit of detection for the standard solution was 5.0 
ng/ml and for the drug in urine was 14.0 ng/ml. The 
results obtained from the analysis of commercial 
tablets were compared statistically with those 
obtained from the USP 26 high-performance liquid 
chromatographic (HPLC) method. 
3.3 Spectrophotometric method 
(A) Diffuse reflectance near infrared spectroscopy  
Ferreira et al[17] developed and validated a 
new multivariate diffuse reflectance near infrared 
method for direct determination of 
Hydrochlorothiazide in powder pharmaceutical 
samples. The best partial least squares (PLS) model 
was obtained in the spectral region from 1640 to 
1780 nm, with mean centered data preprocessed by 
first derivative and Savitzky–Golay smoothing 
followed by vector normalization. The method was 
validated according to the appropriate regulations in 
the range from 21.25 to 29.00 mg of 
Hydrochlorothiazide per 150 mg of powder (average 
mass tablet), by the estimate of figures of merit, such 
as accuracy, precision, linearity, analytical 
sensitivity, capability of detection, bias and residual 
prediction deviation (RPD). 
(B) UV Spectroscopic method 
Darwish et al[18] were developed and 
validated for the simultaneous estimation of 
Amlodipine (AML), Valsartan (VAL) and 
Hydrochlorothiazide (HCTZ) in commercial tablets. 
The derivative spectrophotometric methods include 
Derivative Ratio Zero Crossing (DRZC) and Double 
Divisor Ratio Spectra-Derivative Spectrophotometry 
(DDRS-DS) methods, while the multivariate 
calibrations used are Principal Component 
Regression (PCR) and Partial Least Squares (PLS). 
The proposed methods were applied successfully in 
the determination of the drugs in laboratory-prepare 
mixtures and in commercial pharmaceutical 
preparations. The validity of the proposed methods 
was assessed using the standard addition technique. 
The linearity of the proposed methods is investigated 
in the range of 2-32, 4-44 and 2-20 µg/mL for AML, 
VAL and HCTZ, respectively. 
A Comparative study between univariate 
spectrophotometry and multivariate calibration as 
analytical tools for simultaneous quantitation of 
Moexipril and Hydrochlorothiazide were carried out. 
The first method is the new extended ratio 
subtraction method (EXRSM) coupled to ratio 
subtraction method (RSM) for determination of both 
drugs in commercial dosage form. The second and 
third methods are multivariate calibration which 
includes Principal Component Regression (PCR) and 
Partial Least Squares (PLSs). A detailed validation of 
the methods was performed following the ICH 
guidelines and the standard curves were found to be 
linear in the range of 10-60 and 2–30 for MOX and 
HCTZ in EXRSM method,  respectively, with well 
accepted mean correlation coefficient for each 
analyte [19].  
Two new simple and selective assay 
methods have been presented for the analysis of 
eprosartan mesylate (EPR) and Hydrochlorothiazide 
(HCTZ) in pharmaceutical formulations. The first 
method is based on first-derivative ultraviolet 
spectrophotometry with zero- crossing measurements 
at 246 and 279 nm for EPR and HCTZ, respectively. 
The assay was linear over the concentration ranges 
3.0–14.0 mg/mL for EPR and 1.0–12.0 mg/mL for 
HCTZ. The quantification limits for EPR and HCTZ 
were found to be 1.148 and 0.581 mg/mL, 
respectively, while the detection limits were 0.344 
mg/mL for EPR and 0.175 mg/mL for HCTZ. The 
second method involved isocratic reversed-phase 
liquid chromatography using a mobile phase 
composed of acetonitrile –10 mM phosphoric acid ( 
pH 2.5) (40:60, v/v). Olmesartan was used as internal 
standard and the substances were detected at 272 nm. 
The linearity ranges were found to be 0.5–30 and 
0.3–15.0 mg/mL for EPR and HCT, respectively. The 
limits of detection were found to be 0.121 mg/mL for 
EPR and 0.045 mg/mL for HCTZ. The limits of 
quantification were found to be 0.405 and 0.148 
mg/mL for EPR and HCTZ, respectively [20].  
A simple, precise, accurate and economic 
simultaneous UV spectrophotometric method has 
been developed for the estimation of amlodipine 
besylate, valsartan and hydrochlorothiazide in 
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combination in bulk mixture and tablet. The 
estimation was based upon measurement of 
absorbance at absorbance maxima of 359 nm, 317 nm 
and 250 nm for amlodipine besylate, 
Hydrochlorothiazide and valsartan in methanol, 
respectively in bulk mixture and tablet. The Beer 
Lambert’s law obeyed in the concentration range 5-
25 µg/ml, 10-50 µg/ml and 5-25 µg/ml for 
amlodipine besylate, Hydrochlorothiazide and 
valsartan, respectively [21]. 
Bhatia et al[22] presented simple 
spectrophotometric method development for 
simultaneous estimation of Losartan Potassium 
(LOS) and Hydrochlorothiazide (HCTZ) in two 
component tablet formulation. The method employed 
is a first order derivative spectroscopy. For 
determination of sampling wavelength, 20 µg/ml of 
each of LOS and HCTZ were scanned in 200-400 nm 
range and sampling wavelengths were 257 nm for 
LOS where HCT showed zero crossing point and 243 
nm for HCT where LOS showed zero crossing point 
in first order derivative spectroscopy. For this 
method, linearity observed in this method in the 
range of 10-90 µg/ml for LOS and 2.5-22.5 µg/ml for 
HCTZ. 
Naguib et al[23] has developed Partial least 
squares regression (PLSR) and support vector 
regression (SVR) are two popular chemometric 
models. The comparison shows their characteristics 
via applying them to analyze Hydrochlorothiazide 
(HCTZ) and Benazepril hydrochloride (BZ) in 
presence of HCTZ impurities; Chlorothiazide (CT) 
and Salamide (DSA) as a case study. The analysis 
results prove to be valid for analysis of the two active 
ingredients in raw materials and pharmaceutical 
dosage form through handling UV spectral data in 
range (220–350 nm). An independent test set 
consisting of 8 mixtures was used to validate the 
prediction ability of the suggested models.  
A new simple spectrophotometric method 
was developed for the determination of binary 
mixtures without prior separation. The method is 
based on the generation of ratio spectra of compound 
X by using a standard spectrum of compound Y as a 
divisor. The method was demonstrated by 
determination of two drug combinations. The first 
consists of the two antihyperlipidemics: atorvastatin 
calcium (ATV) and ezetimibe (EZE), and the second 
comprises the antihypertensives: candesartan cilexetil 
(CAN) and Hydrochlorothiazide (HCTZ). For 
mixture 1, ATV was determined using 10 mg/mL 
EZE as the divisor to generate the ratio spectra, and 
the peak to trough amplitudes between 231 and 276 
nm were plotted against ATV concentration. 
Similarly, by using 10 mg/mL ATV as divisor, the 
peak to trough amplitudes between 231 and 276 nm 
were found proportional to EZE concentration. 
Calibration curves were linear in the range 2.5–40 
mg/mL for both drugs. For mixture 2, divisor 
concentration was 7.5 mg/mL for both drugs. CAN 
was determined using its peak to trough amplitudes at 
251 and 277 nm, while HCTZ was estimated using 
the amplitudes between 251 and 276 nm[24].  
Multivariate spectrophotometric calibration 
for the simultaneous analysis of synthetic samples 
and commercial tablet preparations containing 
Hydrochlorothiazide (HCTZ) and amiloride 
hydrochloride (AMH) were developed by Ferraro et 
al.[25] The method, validated by the analysis of 
synthetic mixtures of both drugs, where accuracy 
over the linear working range as well as inter- and 
intra-assay precision were determined, was used in 
the concentration ranges of 21.7-30.4 µg/l  for HCTZ 
and 1.8.3.0 µg/l for AMH.  
Different spectrophotometric and HPTLC-
densitometric methods are presented for the 
simultaneous determination of lisinopril and 
hydrochlorothiazide in pharmaceutical tablets. The 
spectrophotometric methods include third derivative 
(3D) ultraviolet spectrophotometry with zero crossing 
measurement at 217.4 and 233.4 nm, second 
derivative of the ratio spectra with measurement at 
214.3 and 228.0 nm; both classical least squares and 
principal component regression were applied to the 
UV absorption and first derivative spectra of the 
mixture. The HPTLC method was based on 
separation of both drugs followed by densitometric 
measurements of their spots at 210 and 275 nm 
forlisinopril and Hydrochlorothiazide, 
respectively[26]. 
Abdelwahab[27] developed the 
spectrophotometric methods for simultaneous 
determination of Carvedilol (CV) and 
Hydrochlorothiazide (HCTZ) in bulk powder and 
combined dosage form. Method (I) is based on dual 
wavelength analysis while Method (II) depends on 
UV-spectrophotometric determination using Q-
analysis (graphical absorbance ratio) method. In 
Method (I), two wavelengths were selected for each 
drug in such a way that the difference in absorbance 
is zero for the second drug. At wavelengths 238 and 
248.8 nm HCTZ has equal absorbance values, 
therefore, these two wavelengths have been used to 
determine CV, on similar basis 266 and 289.4 nm 
were selected to determine HCTZ in the combined 
formulation. Method (II) involves the formation of 
Q-absorbance equation using the respective 
absorptivity values at 229.2 nm (isoabsorptive point) 
and 241 nm (k of CV). The drugs obey Beer’s 
Lambert’s law in the concentration range of 1–10 
µg/mL for both CV and HCTZ (for Method I) and in 
the range of 1–10 and 2–10 µg/mL for CV and HCT, 
respectively (for Method II). The accuracy and 
precision max were determined and recovery studies 
confirmed the accuracy of the developed methods 
that were carried out following the International 
Conference on Harmonization (ICH) guidelines.  
Simultaneous determination of Losartan 
potassium (LSP) and Hydrochlorothiazide (HCTZ) in 
a binary mixture form has developed by Rao et 
al[28]. The present work was carried out on 
Shimadzu electron UV1800 double beam UV-Visible 
spectrophotometer. The absorption spectra of 
reference and test solutions were carried out in 1 cm 
matched quartz cell over the range of 200-400 nm. 
The first method is the application of simultaneous 
equation. Where the linearity ranges for LSP and 
HCTZ were 5–25 µg/ml and 1–20 µg/ml, 
respectively. The second method is the determination 
of ratio of absorbance at 272 nm, the maximum 
absorption of HCTZ and isobestic wavelength 
266.5nm, the linearity ranges for LSP and HCTZ 
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were 5-80µg/ml and 1-25µg/ml respectively. The 
third method is the first order derivative method, 
where the linearity ranges for LSP and HCTZ were 1-
30 µg/ml and 1-40 µg/ml respectively[28].  
3.4 Chromatographic method 
(A) High performance liquid chromatography 
A simple and precise high performance 
liquid chromatographic method has been developed 
and validated for the simultaneous determination of 
bisoprolol fumarate (BF) and hydrochlorothiazide 
(HCTZ) in a tablet formulation. Chromatography was 
carried out at 25C on a 4.6 mm×250 mm, 5 µm cyano 
column with the isocratic mobile phase of 0.1 M 
aqueous phosphate buffer, acetonitrile and 
tetrahydrofuran (85:10:5, v/v/v) at a flow rate of 1.0 
ml/min. The UV detection was carried out at 225 nm. 
HCTZ and BF were separated in less than 10 min 
with good resolution and minimal tailing, without 
interference of excipients. The method was validated 
according to ICH guidelines and the acceptance 
criteria for accuracy, precision, linearity, specificity 
and system suitability were met in all cases. The 
method was linear in the range of 50–150 µg/ml for 
BF and 125–375 µg/ml for HCTZ[29]. 
Alton et al[30] developed high-performance 
liquid chromatographic assay was developed for the 
quantitative determination of Hydrochlorothiazide 
(HCTZ) in human urine. Reversed-phase separation 
of HCT and the internal standard, trlchloromethiazide 
(TCMT), was accomplished on a 300 x 3.9 mm 
NBondapak Phenyl column has been routinely 
employed in bioavailability studies evaluating a 
variety of formulations as well as characterizing the 
pharmacokinetics of this drug from urinary excretion 
data. 
Simultaneous high performance liquid 
chromatographic analysis of serum samples and 
commercial tablet formulation containing 
hydrochlorothiazide, olmesartan medoxomil and 
irbesartan were developed by Najma et al[31]. Good 
chromatographic separation was achieved using N -
Bondapak, Ccolumn (15 cm 4.6 mm, 5 m), and a 
mobile phase consisting of acetonitrile -0.2% acetic 
acid aqueous solution (5050, v/v) at a flow rate of 1.0 
mL/min. The ultraviolet detector was set at a 
wavelength of 260 nm. hydrochlorothiazide, 
olmesartan medoxomil, and irbesartan were eluted at 
1.2, 3.8, and 4.4 min, respectively. The linear ranges 
for Hydrochlorothiazide, Olmesartan medoxomil, and 
Irbesartan were 6.25–18.75, 20–60, and 75–225 
ng/mL, respectively. The recoveries of 
hydrochlorothiazide, olmesartan medoxomil, and 
irbesartan in spiked samples were all greater than 
98%, and their relative standard deviations were less 
than 2.0%.  
A simple, rapid, and precise method was 
developed for the quantitative simultaneous 
determination of telmisartan and hydrochlorothiazide 
in combined pharmaceutical dosage form. 
Chromatographic separation of two drugs was 
achieved on an ACE 5 C1825-cm analytical column 
using buffer–acetonitrile (60:40, v/v) of pH 5.5, 
adjusted with acetic acid. The method was validated 
for linearity, accuracy, precision, limit of detection, 
limit of quantification, and robustness. The 
calibration curve shows excellent linearity over the 
concentration range for telmisartan and 
hydrochlorothiazide were 10–150 and 5–75 µg/mL, 
respectively. The correlation coefficient for 
telmisartan and hydrochlorothiazide were 0.9999[32]. 
Suchara et al[33]described the quantitation 
of target analytes in complex matrices such as 
biological samples require special calibration 
approaches to compensate for additional capacity or 
activity in the matrix samples. The performance of 
the analytical method was evaluated. Relative 
standard deviation, limit of detection, and limit of 
quantification are respectively 0.5–0.6%, 0.169–0.75 
µg/mL, and 0.565–2.5 µg/mL. Linear range falls 
within the range of 0.3 to 63.8 µg/mL for both 
compounds. Accuracy ranged between 94% and 
101%. 
Hegazy [34] developed and validated a 
stability indicating chromatographic methods for 
Hydrochlorothiazide (HCTZ) and Spironolactone 
(SPR) determination in their mixtures and in presence 
of their impurities and degradation products. The first 
method was based on thin layer chromatographic 
(TLC) combined with densitometric determination of 
the separated spots. The separation was achieved 
using silica gel 60 F TLC plates and ethyl acetate–
chloroform– formic acid–triethyl amine (7:3:0.1:0.1, 
by volume) as a developing system. The second 
method was based on the high-performance liquid 
chromatography with ultraviolet detection, by which 
the proposed components were separated on a 
reversed phase C18analytical column using gradient 
elution system with deionized water–acetonitrile 
(97:3, v/v) for 8 min. The flow rate was maintained at 
2 mL/min and the detection wavelength was at 230 
nm. Linear regressions were obtained in the range of 
4.0–50 µg/mL and 5.0–50 µg/mL for both HCTZ and 
SPR, respectively.  
A Liquid chromatographic method for the 
determination of hydrochlorothiazide in human 
plasma was presented by Miller el al[35]. The 
reported method herein for the determination of 
HCTZ is linear over the range of 2.0-1000 ngml
-1
 in 
human plasma.  
(B) High performance liquid chromatography with 
UV spectroscopy 
The development of a reversed phase liquid 
chromatographic method for the simultaneous 
determination of seven angiotensin converting 
enzyme (ACE) inhibitors were developed  by 
Elsebaei et al[36]. The method utilizes a simple 
gradient procedure for the separation in a 11 min run 
time using acetonitrile aqueous ammonia buffer (pH 
9) solution and an Extend RP-C18 (25 µm particle 
size, 4.6 mm×250 mm, Agilent) HPLC column. The 
effluent was monitored on a UV detector at 215 nm. 
The limits of detection (LOD) and limits of 
quantification (LOQ) from standard drug solutions lie 
in the range of 17–64 and 56–212 ngml-1, 
respectively. Correlation coefficient values (r) higher 
than 0.997 were obtained for all the studied drugs in 
spiked human plasma and urine samples. 
High performance liquid chromatography 
(HPLC) was developed for the simultaneous 
determination of Telmisartan (TELM) and 
Hydrochlorothiazide (HCTZ) in human plasma using 
indapamide as internal standard. The method utilizes 
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proteins precipitation with acetonitrile as only sample 
preparation prior to RP-HPLC. The analytes were 
chromatographed on shim-pack cyanopropyl column 
in isocratic elution with methanol: 10 mM 
ammonium acetate solution (pH 6.0) (35:65 v/v) as 
mobile phase at a flow rate of 1 ml/min and the 
wavelength of detection was 270 nm. The method 
was validated over the concentration range of 1–10 
µg/ml for TELM and 0.31– 3.12 µg/ml for HCTZ in 
human plasma. Inter- and intra-run precision of 
TELM and HCTZ were less than 3.60% and the 
accuracy was less than 1.868% [37]. 
(C) Reverse phase high performance liquid 
chromatography 
Reversed-phase column liquid 
chromatographic method has been developed and 
validated for the simultaneous determination of 
Zofenopril (ZOF) and Hydrochlorothiazide (HCTZ) 
in pharmaceutical preparations. Analyses were 
carried out on a C18 column using methanol-water 
(pH 2.5 with H3PO4) as the mobile phase, delivered 
in a gradient mode. Detection was performed using 
an UV–vis detector monitored at 270 nm. 
Quantitation was achieved using an external 
calibration curve. The linearity for ZOF 
concentrations ranging between 1.0–70.0 µg/mL, and 
between 2.5–35.0 µg/mL for HCTZ (r > 0.999) was 
established. The recovery (R %) of the active 
ingredients from the samples ranged between 99.42% 
and 100.67%. Intra- and inter-day precisions were 
less than 1.5%. The limits of detection (LOD) and 
quantitation (LOQ) were 0.129 and 0.292 µg/mL for 
ZOF, and 0.183 and 0.556 µg/mL for HCTZ, 
respectively [38].  
Sheth et al[39] Describe simultaneous 
estimation of rosuvastatin calcium and 
hydrochlorothiazide from bulk and 
commercialproducts using a validated reverse phase 
high performance liquid chromatographic technique. 
The separation of both the drugs was achieved on 
ACE C18 AR (AR - Aromatic) column (250 × 4.6 
mm, 5 µm) using a mobile phase of sodium 
perchlorate buffer solution (at pH 3.0): Acetonitrile 
(60:40 v/v). The flow rate was 1 ml/min and 
detection was done at 280 nm. The retention time for 
Hydrochlorothiazide was 3.9 min and for 
Rosuvastatin calcium was 10.3 min. Rosuvastatin 
calcium and Hydrochlorothiazide showed a linear 
response in the concentration range of 5-30 µg/ml 
and 6.25-37.5 µg/ml respectively. The correlation co-
efficients for Rosuvastatin calcium and 
Hydrochlorothiazide were 0.9998 and 0.9999 
respectively. The percentage recoveries obtained for 
Rosuvastatin calcium and Hydrochlorothiazide range 
from 99.3% to 100.4% and 99.2% to 100.4% 
respectively. The results of analysis have been 
validated as per the International conference on 
Harmonisation (ICH) guidelines.  
A simple, sensitive and specific liquid 
chromatographic method with UV detection (230 
nm) was developed for the simultaneous estimation 
of Hydrochlorothiazide, amlodipine and losartan in 
tablet dosage form and Telmisartan as an internal 
standard. Separation was achieved with a 
phenomenexluna 5µ CN100R, 250 × 4.60 mm5 
micron size column, ambient temperature with a low 
pressure gradient mode with mobile phase containing 
acetonitrile, water and 0.4% of potassium dihydrogen 
phosphate buffer pH 2.7 adjusted with 
orthophosphoric acid (45:35:20). The flow rate was 1 
mL min
-1
 and eluent was monitored at 230 nm. The 
linearity range of hydrochlorothiazide, amlodipine 
and losartan found in the range of 12.5-62.5 µg ml
-1
, 
2.5-12.5 µg ml
-1
methodand 20-250 µg ml
-
1
respectively[40].  
 Reversed phase high performance liquid 
chromatography (RP-HPLC) method was developed 
for determination of related substances of 
Telmisartan and Hydrochlorothiazide in tablet dosage 
form presented by Mukhopadhyay et al[41]. 
Simultaneous determination of related substances 
was performed on Kromasil C18 analytical column 
(250 × 4.6 mm; 5µm particle size) column at 40°C 
employing a gradient elution. Mobile phase 
consisting of solvent A (solution containing 2.0 g of 
potassium dihydrogen phosphate anhydrous and 1.04 
g of Sodium 1- Hexane sulphonic acid monohydrate 
per liter of water, adjusted to pH 3.0 with 
orthophosphoric acid) and solvent B (mixture of 
Acetonitrile: Methanol in the ratio 80:20 v/v) was 
used at a flow rate of 1.0 ml/min. UV detection was 
performed at 270 nm. 
Joshi et al[42] developed HPLC method for 
the simultaneous determination of Bisoprolol 
fumarate and Hydrochlorothiazide in pharmaceutical 
dosage form. The separation was achieved on an 
Inertsil ODS 3V (25 cm×4.6 mm) 5 µm column with 
isocratic flow. The mobile phase at a flow rate of 1.0 
mL min
-1
 consisted of 0.1 M potassium dihydrogen 
phosphate buffer and acetonitrile (70:30, v/v). The 
UV detection was carried out at 228 nm. A linear 
response was observed over the concentration range 
2.5–50 µg ml-1of Bisoprolol fumarate and the 
concentration range 6.25–125 µg ml-1of 
hydrochlorothiazide. Limit of detection and limit of 
quantitation for bisoprolol fumarate were 0.01 and 
0.03 µg/mL, respectively and for hydrochlorothiazide 
were 0.01 and 0.05µg ml
-1
, respectively. 
High pressure liquid chromatographic 
method has been developed for the simultaneous 
estimation of Nebivolol and Hydrochlorothiazide 
from pharmaceutical formulation.  Phenomenex 
Gemini C18(25 cm×4.6 mm i.d, 5 µ) column with a 
mobile phase consisting of acetonitrile: 
50mMammonium acetate (adjusted to pH 3.5 using 
orthophosphoric acid) (70:30 v/v) at a flow rate of 
1.0 ml/min was used. Detection was carried out at 
254 nm. Probenecid was used as an internal standard. 
The retention times of probenecid, Nebivolol and 
Hydrochlorothiazide were 13.05, 3.32 and 4.25 min, 
respectively[43].  
Rawool et al[44]  Presented RP-HPLC 
method of two different drug components 
hydrochlorothiazide and metoprolol tartrate present 
in a tablet formulation. It is a simple, fast, precise and 
accurate high performance liquid chromatographic 
method. It is performed using phosphate buffer along 
with methanol as mobile phase, in the proportion of 
60:40. The separation is done on a C18column and it 
is estimated at 226 nm with a flow of 1 ml/min. The 
detection limits range from a 0.013 to 0.075 mg/ml 
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for Hydrochlorothiazide and 0.10 to 0.60 mg/ml for 
metoprolol tartrate, respectively. 
(D) Stability indicating chromatographic method 
A simple and selective HPLC-DAD stability 
indicating method was developed for the 
simultaneous determination of the three 
antihypertensive drugs amlodipine besylate (AML), 
valsartan (VAL) and Hydrochlorothiazide (HCTZ) in 
their combined formulation describe by Shaalan et 
al[45]. Effective chromatographic separation was 
achieved using Zorbax SB-C8 column (4.6 × 250 
mm, 5 µm ps) with gradient elution of the mobile 
phase composed of 0.025 M phosphoric acid and 
acetonitrile at a flow rate of 1 mL/min. The multiple 
wavelength detector was set at 238 nm for 
measurement of AML and 225 nm for both VAL and 
HCTZ. Quantification was based on measuring the 
peak areas. The three compounds were resolved with 
retention times of 4.9, 6.4 and 8.3 min for HCTZ, 
AML and VAL respectively.  
Jain et al[46] A simple, specific, accurate 
and precise stability-indicating reversed-phase high-
performance liquid chromatographic method was 
developed for simultaneous estimation of olmesartan 
medoxomile (OLME), amlodipine besylate (AMLO) 
and hydrochlorothiazide (HCTZ) in tablet dosage 
form. The method was developed using an RP C18 
base deactivated silica column (250 × 4.6 mm, 5 µm) 
with a mobile phase consisting of triethylamine(pH 
3.0) adjusted with orthophosphoric acid (A) and 
acetonitrile (B), with a timed gradient program of T 
%B: 0/30, 7/70, 8/30, 10/30 with a flow rate of 1.4 
mL/min. Ultraviolet detection was used at 236 nm. 
The retention times for OLME, AMLO and HCTZ 
were found to be 6.72, 4.28 and 2.30 respectively.  
Stability study of 
losartan/Hydrochlorothiazide tablets is presented by 
Lusina et al[47]. Losartan (angiotensin II receptor 
antagonist) and Hydrochlorothiazide (diuretic) are 
successfully used in association in the treatment of 
hypertension. Stability study of 
losartan/Hydrochlorothiazide tablets consisted of 
three steps: stress test (forced degradation study), 
preliminary testing (selection of packaging) and 
formal stability testing. Based on the first 12 months 
of the formal stability study, a shelf life of 24 months 
was proposed.  
Rane et al[48] presented stability-indicating 
liquid chromatography Method is developed and 
validated for the quantitative simultaneous estimation 
of Irbesartan (IRB) and Hydrochlorothiazide (HCTZ) 
in combined pharmaceutical dosage form. A 
chromatographic separation of the two drugs was 
achieved with an Ace5 C1825-cm analytical column 
using buffer–acetonitrile (70:30 v/v). The buffer used 
in mobile phase contains 50 mM ammonium acetate 
pH adjusted 5.5 with acetic acid. The instrumental 
settings are flow rate of 1.5 mL/min, column 
temperature at 30°C, and detector wavelength of 235 
nm using a photodiode array detector. Peak 
homogeneity data of IRB and HCTZ is obtained 
using photodiode array detector. The described 
method shows excellent linearity over a range of 10–
200 µg/mL for IRB and 5–100 µg/mL for HCTZ. 
Methylparaben was used as internal standard. The 
correlation coefficient for IRB and HCTZ are 0.998 
and 0.999. The mean recovery values for IRB and 
HCTZ ranged from 100.45% to 101.25%. The limit 
of detection for IRB and HCTZ were 0.019 and 0.023 
µg/mL, respectively, and the limit of quantification 
was 0.053 and 0.070 µg/mL respectively. 
The ultimate goal of this work was to 
develop and validate a single high-performance 
liquid chromatography method selective for the eight 
main components of tablets HYZAAR.A single 
method was developed to afford simultaneous 
quantitation of actives and degradates for each of the 
two existing formulations. Each method is presented 
herein and demonstrated to be suitable for 
quantitation to 0.1% levels of all relevant degradates, 
as well as 100% levels of respective drug 
substances[49]. 
(E) High performance thin layer chromatographic 
method 
A simple, precise, accurate and rapid high 
performance thin layer chromatographic method has 
been developed and validated for the simultaneous 
estimation of Irbesartan and Hydrochlorothiazide in 
combined dosage forms[50]. The stationary phase 
used was precoated silica gel 60F254. The mobile 
phase used was a mixture of acetonitrile: chloroform: 
glacial acetic acid (7:3:0.1 v/v/v). The detection of 
spots was carried out at 260 nm. The method was 
validated in terms of linearity, accuracy, precision 
and specificity. The calibration curve was found to be 
linear between 100 to 700 ng/spot for irbesartan and 
100 to 350 ng/spot for hydrochlorothiazide. The limit 
of detection and the limit of quantification for the 
Irbesartan were found to be 30 and 100 ng/spot 
respectively and for hydrochlorothiazide 25 and 100 
ng/spot respectively.  
Different spectrophotometric and HPTLC-
densitometric methods are presented by Alaa El-
Gindy et al[51] for the simultaneous determination of 
lisinopril and hydrochlorothiazide in pharmaceutical 
tablets. The spectrophotometric methods include 
third derivative (D) ultraviolet spectrophotometry 
with zero crossing measurement at 217.4 and 233.4 
nm, second derivative of the ratio spectra with 
measurement at 214.3 and 228.0 nm; The HPTLC 
method was based on separation of both drugs 
followed by densitometric measurements of their 
spots at 210 and 275 nm for lisinopril and 
hydrochlorothiazide, respectively. The separation 
was carried out on Merck HPTLC aluminum plates 
of silica gel 60 F254, using chloroform–ethylacetate–
acetic acid (10:3:2 by vol.) as mobile phase.  
Khodke et al[52] The presented 
development and validation of a stability indicating 
HPTLC method for simultaneous estimation of 
Irbesartan and Hydrochlorothiazide using TLC plates 
precoated with Silica gel 60F254 and the mobile 
phase comprising Acetonitrile: Chloroform in the 
ratio of 5:6 v/v. Irbesartan and Hydrochlorothiazide 
were well resolved with Rf 0.27 ± 0.03 and 0.45 ± 
0.03, respectively. Wavelength selected for the 
quantization was 270 nm. Inherent stability of these 
drugs was studied by exposing both drugs to various 
stress conditions as per ICH guidelines viz. Dry heat, 
oxidative, photolysis (UV and cool white fluorescent 
light) and hydrolytic conditions under different pH 
values.  
Review Article                                                                             Savaj Bhadresh Vet al /2015
 
 
                                                           29 
 
(F) High performance liquid chromatography 
coupled with mass spectrometry 
A sensitive, specific and selective method 
has been developed for the simultaneous 
determination of Bisoprolol and Hydrochlorothiazide 
in human plasma presented by Tutunji et al[53]. The 
method employed a state of the art LC–MS/MS 
operated in the positive and negative ionization 
switching modes. A simple sample preparation step 
involving protein precipitation with acetonitrile has 
been optimized; the analytes and the internal standard 
moxifloxacin were separated on a Purosphere®STAR 
C8column (125 mm×4 mm, 5 µm). The mobilephase 
was an ammonium acetate solution (1 mM) with 
formic acid (0.2%): methanol and acetonitrile 
(65:17.5:17.5, v/v/v (%)), the flow rate was set at 
0.65 mL/min. Linearity was demonstrated over the 
concentration range 0.10–30.0 (ng/mL) for 
Bisoprolol and 1.00–80.00 ng/mL for 
hydrochlorothiazide. The limits of detection were 
0.100 (ng/mL) for bisoprolol and 1.00 (ng/mL) for 
hydrochlorothiazide. The validated method was 
successfully applied to a pharmacokinetic study of 5 
mg bisoprolol fumarate with 12.5 mg 
hydrochlorothiazide tablet in healthy volunteers. 
Parekh et al[54] described a rapid and 
sensitive liquid chromatography-tandem mass 
spectrometry (LC-MS/MS) method has been 
developed and validated for the simultaneous 
estimation of hydrochlorothiazide, quinapril and its 
metabolite quinaprilat in human plasma. After solid 
phase extraction (SPE), the analytes and IS were 
chromatographed on a hypurity C8 (100 mm×2.1 mm 
i.d, 5 µm particle size) column using 2 µL injection 
volume with a run time of 2.8 min. An isocratic 
mobile phase consisting of 0.5% (v/v) formic acid: 
acetonitrile (25:75, v/v) was used to separate all these 
drugs. The precursor and product ions of these drugs 
were monitored on a triple quadrupole mass 
spectrometer, operating in the multiple reaction 
monitoring mode (MRM) without polarity switch. 
The proposed method was validated over the range of 
5–500 ng/mL for hydrochlorothiazide method and 5–
1500 ng/mL for quinapril and quinaprilat.  
High performance liquid chromatography 
coupled to tandem mass spectrometry (HPLC-
MS/MS) was developed for the simultaneous 
determination of olmesartan (OLM) and 
hydrochlorothiazide (HCTZ) in human plasma and 
urine. Solid-phase extraction (SPE)was used to 
isolate the analytes from biological matrices followed 
by injection of the extracts onto a C18column with 
isocratic elution. Detection was carried out on a triple 
quadrupole tandem mass spectrometer in multiple 
reaction monitoring (MRM) mode using negative 
electrospray ionization (ESI). The method was 
validated over the concentration range of 1.00–1000 
ng/mL and 5.00–5000 ng/mL for OLM in human 
plasma and urine as well as 0.500–200 ng/mL and 
25.0–25,000 ng/mL for HCTZ in human plasma and 
urine, respectively[55].  
A rapid and sensitive method for the 
simultaneous quantitation of hydrochlorothiazide 
(HCTZ) and metoprolol (MET) in human plasma 
based on liquid chromatography–tandem mass 
spectrometry (LC–MS/MS) has been developed and 
validated by Gao et al[56]. Sample preparation by 
liquid–liquid extraction with diethyl ether–
dichloromethane (60:40, v/v) was followed by 
chromatography on a Venusil MP-C18 column using 
methanol–ammonium acetate (10 mM)–formic acid 
(pH 3.4) (50:50:0.05, v/v/v) at a flow rate of 0.8 
mL/min. The method was linear in the concentration 
range 3–1000 ng/mL for both HCT and MET using 
100 µL human plasma. Intra- and inter-day precisions 
(as relative standard deviation) for HCT were 2.9–
3.9% and 3.9–4.7%, respectively and for MET were 
2.4–4.1% and 4.7–6.2%, respectively. Accuracies 
were ±3.8% and ±2.6% for HCT and MET, 
respectively.  
Gadepalli et al[57] developed novel and 
accurate liquid chromatography tandem mass 
spectrometry method using electrospray ionization 
mode has been developed and validated for the 
simultaneous determination of amlodipine (AMD), 
valsartan (VAL) using losartan (LOS) as an internal 
standard (IS), and Hydrochlorothiazide (HCTZ) 
using furosemide (FSD) as an IS. The separation was 
carried on Aquasil C18(50 mm  × 2.1 mm, 5 µm) 
reversed phase column using acetonitrile and water 
containing 0.1% formic acid (50:50, v/v) as the 
mobile phase. The method was validated in terms of 
linearity, accuracy and precision over the 
concentration range of 1–1000 ng/mL. 
A sensitive, specific and selective liquid 
chromatography/tandem mass spectrometric method 
has been developed and validated for the 
simultaneous determination of irbesartan and 
hydrochlorothiazide in human plasma. Plasma 
samples were prepared using protein precipitation 
with acetonitrile, the two analytes and the internal 
standard losartan were separated on a reverse phase 
C18column (50 mm×4 mm, 3 µm) using water with 
2.5% formic acid, methanol and acetonitrile 
(40:45:15, v/v/v (%)) as a mobile phase (flow rate of 
0.70 mL/min[58].  
Singh et al[59] Validated ultra-performance 
liquid chromatography mass spectrometric method 
(UPLC–MS/MS) was used for the simultaneous 
quantitation of candesartan (CN) and 
hydrochlorothiazide (HCTZ) in human plasma. The 
analytes were extracted using a liquid–liquid 
extraction (LLE) method by using 0.1 mL of plasma 
volume. The lower limit of quantitation for CN and 
HCT was 1.00 ng/mL whereas the upper limit of 
quantitation was 499.15 ng/mL and 601.61 ng/mL for 
CN and HCTZ respectively. The chromatography 
was achieved within 2.0 min run time using a C18 
Phenomenex, Gemini NX (100 mm ×4.6 mm, 5 mm) 
column with organic mixture: buffer solution (80:20, 
v/v) at a flow rate of 0.800 mL/min. 
An ultra-high performance liquid 
chromatography tandem mass spectrometry (U-
HPLC–MS/MS) method was developed and validated 
to determine irbesartan (IRB) and 
hydrochlorothiazide (HCTZ) in human plasma 
simultaneously presented by Qiu et al[60]. Plasma 
samples were prepared using protein precipitation 
with acetonitrile, the two  analytes and the internal 
standard losartan were separated on an Acquity U-
HPLC BEH C18 column and mass spectrometric 
analysis was performed using a QTrap5500 mass 
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spectrometer coupled with an electro-spray ionization 
(ESI) source in the negative ion mode. The MRM 
transitions of m/z 427.2 → 206.9 and m/z 296.1 → 
204.9 were used to quantify for IRB and HCTZ, 
respectively. The linearity of this method was found 
to be within the concentration range of 5–3000 
ng/mL for IRB, and 0.5–300 ng/mL for HCT in 
human plasma, respectively. The lower limit of 
quantification (LLOQ) was 5 ng/mL and 0.5 ng/mL 
for IRB and HCTZ in human plasma, respectively 
[60].  
(G) HPLC with on-line solid-phase extraction 
Shang et al[61] described a HPLC method 
with on-line solid phase extraction (SPE) and DAD 
detection was developed for the simultaneous 
determination of nitrendipine and 
hydrochlorothiazide in spontaneously hypertensive 
rat (SHR) plasma. Plasma samples (100 µL) were 
injected directly onto a CAPCELL MF C8 SPE 
column. High-abundance proteins and most matrixes 
in plasma were removed by on-line SPE technology, 
while nitrendipine and hydrochlorothiazide trapped 
on the SPE column were effectively separated on a 
C18analyticalcolumn. The column temperature was 
maintained at 20 °C. The optimal detection 
wavelength was 237 nm for NTDP and 271 nm for 
HCTZ. The total analytical run time was 34 min. The 
proposed method was linear over the range 5–500 
ng/mL for nitrendipine and 10–1000 ng/mL for 
hydrochlorothiazide. The lower limit of detection 
(LLOD) was 0.5 and 0.6 ng/mL for nitrendipine and 
hydrochlorothiazide, respectively. 
(H) Thin layer chromatography 
TLC simultaneous determination of 
valsartan (VAL) and hydrochlorothiazide (HCTZ) in 
pure form and in tablets using new butyl-modified 
Aleppo bentonite (BAC4) with mobile phase of 
acetonitrile: water: acetic acid (49.35:49.35:1.3, v/v), 
at pH 3.2 and at wavelength λ= 260 nm was 
developed. The surface properties of butyl-modified 
bentonite were studied by nitrogen adsorption at 77K. 
The retardation factors (Rf) of valsartan and 
hydrochlorothiazide were 0.49 and 0.78, respectively. 
Linearity for determination of VAL and HCTZ was 
in the range 2.00-20.00 and 1.00-10.00 µg/spot, 
respectively. The minimum determined concentration 
was 2.0 µg/spot for VAL and 1.0 µg/spot for HCTZ 
with percent relative standard deviation (RSD %) 
does not exceed 3.1% and 2.0%, respectively. The 
limits of quantification (LOQ) were 0.61 and 0.20 
µg/spot, and the limits of detection (LOD) were 0.20 
and 0.066 µg/spot for determination of VAL and 
HCTZ, respectively. The proposed method was 
novel, simple, accurate and successfully applied to 
simultaneous determination of VAL and HCTZ in 
pharmaceuticals with average recovery of 97.9 to 
102.4%, the results obtained agree well with the 
contents stated on the labels [62]. 
 
Table 1: Development Parameters for Chromatographic Methods 
Drugs Method Year Mobile phase(v/v) Column 
Flow rate 
(mL/min) 
Wave 
length 
(nm) 
Ref 
Bisoprolol fumarate and 
Hydrochlorothiazide  
HPLC 
2008 0.1 M aqueous phosphate buffer: 
acetonitrile: tetrahydrofuran 
(80:10:5) 
5 µm cyano 
column 
1 225 29 
Hydrochlorothiazide  HPLC 
1986 0.1 M potassium di-hydrogen 
phosphate: acetonitrile: 
tetrahydrofuran(85:10:5) 
Bondapack 
phenyl column 
2 280 30 
Olmesartan  medoxomil 
and 
Irbesartan and 
Hydrochlorothiazide  
HPLC 
2008 
acetonitrile 
: 0.2% acetic acid  (50:50) 
Bondapak, C18 
column 
 
1 260 31 
Telmisartan and 
Hydrochlorothiazide  
HPLC 
2008 Buffer : acetonitrile (60:40) 
 
ACE 5 C18 
 
1 260 32 
Acetaminophen and 
Hydrochlorothiazide  
HPLC 
2008 
water : methanol (85 : 15) 
MICROSORB-
MV 100 C18 
1.2 254 33 
Hydrochlorothiazide and 
Spironolactone  
HPLC 
2011 
ethyl acetate : chloroform : 
formic acid : triethyl amine 
(7:3:0.1:0.1) 
silica gel 60 
F254 
TLC 
 
2 230 34 
Hydrochlorothiazide  
 
LC 
1992 Sodium phosphate monobasic: 
acetonitrile: methanol (90:6:4) 
Nucleosile C8 
column 
1.2 273 35 
Angiotensin Converting 
Enzyme Inhibitors 
together with 
Hydrochlorothiazide  
HPLC-UV 
2011 
acetonitrile :  ammonia buffer Extend RP- C18 1 215 36 
Telmisartan and 
Hydrochlorothiazide 
HPLC – 
UV 
2011 methanol:  ammonium acetate 
(35: 65) 
cyanopropyl 
column 
1 270 37 
Zofenopril and 
Hydrochlorothiazide 
RP – LC 
2011 Methanol : water (30: 70) 
 
C18 column 1 270 38 
Rosuvastatin calcium and 
Hydrochlorothiazide 
RP – 
HPLC 
2012 
sodium perchlorate buffer 
solution (at pH 3.0): Acetonitrile 
(60:40) 
ACE C18 
AR  
 
 
1 280 39 
Hydrochlorothiazide, 
Amlodipine, 
and Losartan  
RP – 
HPLC 
2013 acetonitrile : water : potassium 
dihydrogen phosphate buffer 
(45:35:20) 
phenomenexlun
a 5µ CN 
1 230 40 
Telmisartan and 
Hydrochlorothiazide 
RP- HPLC 
2011 
Acetonitrile: Methanol (80:20) 
Kromasil C18 
column 
1 270 41 
Bisoprololfumarate and 
Hydrochlorothiazide 
RP- HPLC 
2010 potassium dihydrogen phosphate 
buffer and acetonitrile (70:30) 
Inertsil ODS 
3V  column 
1 228 42 
Nebivolol and 
Hydrochlorothiazide 
RP- HPLC 
2008 acetonitrile: 
ammonium acetate (70: 30) 
Phenomenex 
Gemini C18 
1 254 43 
Hydrochlorothiazide and 
Metoprolol Tartrate  
RP- HPLC 
2011 phosphate buffer: methanol 
(60:40) 
C18 
Column 
1 226 44 
Amlodipine besylate, 
Valsartan and 
Stability 
indicating 
2013 
phosphoric acid : acetonitrile  
Zorbax SB-C8 
column 
1 225 45 
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Hydrochlorothiazide  HPLC- 
DAD 
Olmesartan Medoxomile, 
Amlodipine Besylate and 
Hydrochlorothiazide  
 
Stability 
indicating 
RP – 
HPLC 
2012 
Triethylamine : acetonitrile  RP C18 1.4 236 46 
Losartan/Hydrochlorothia
zide  
Stability 
indicating 
HPLC 
2005 acetonitrile : water : 
orthophosphoric acid : 
triethylamine (400:600:1:1) 
Hypersil ODS 
(C18) column 
1 220 47 
Irbesartan and 
Hydrochlorothiazide 
Stability 
indicating 
LC 
2010 
ammonium acetate : 
acetonitrile.(70 :30) 
Ace5 C18 
 
1.5 235 48 
Losartan potassium, 
Hydrochlorothiazide 
Stability 
indicating 
HPLC 
2002 
phosphate buffer: 
acetonitrile(93: 7) 
C8 columns 1.0 250 49 
Irbesartan and 
Hydrochlorothiazide  
HPTLC 
2007 Acetonitrile : chloroform : 
glacial acetic acid (7:3:0.1) 
- - 260 50 
Lisinopril and 
Hydrochlorothiazide  
Spectro-
photometri
c and 
HPTLC 
2001 
Chloroform : ethylacetate : 
acetic acid 
(10:3:2) 
- - 275 51 
Irbesartan and 
Hydrochlorothiazide 
HPTLC 
2010 
Acetonitrile: Chloroform(5:6) 
Silica gel 
60F254 
- 270 52 
Bisoprolol and 
Hydrochlorothiazide  
HPLC-MS 
2009 
formic acid (0.2%): methanol : 
acetonitrile (65:17.5:17.) 
Purosphere ® 
STAR C8 
Column 
0.65 - 53 
Hydrochlorothiazide, 
Quinapril and Quinaprilat 
LC–MS 
2008 formic acid : acetonitrile 
(25: 75) 
hypurity C8 0.2 - 54 
Olmesartan and 
Hydrochlorothiazide  
LC-MS 
2010 
Acetonitrile : formic 
acid :methanol (60 : 36 :4) 
XTerra MS C18 
 
0.2 min 
during 0-1.2 
min and 
was change 
into 0.35 
ml/min 
during 1.2 – 
2 min 
- 55 
Hydrochlorothiazide and 
Metoprolol 
LC-MS 
2010 methanol :ammonium acetate : 
formic acid  (50:50:0.05) 
Venusil MP-C18 0.8 - 56 
Amlodipine, Valsartan 
and Hydrochlorothiazide  
LC ESI- 
MS/MS 
2003 
acetonitrile : water containing 
0.1 % formic acid (50:50) 
Aquasil 
C18 
 
0.2 - 57 
Irbesartan and 
Hydrochlorothiazide  
HPLC -MS 
2010 
2.5% formic : methanol : 
acetonitrile (40:40:15) 
C18 
column 
 
0.70 - 58 
Candesartan and 
Hydrochlorothiazide  
UPLC-
MS/MS 
2014 organic mixture : buffer solution  
(80:20) 
C18phenomenex 
, Gemini NX 
0.800 - 59 
Irbesartan  and   
Hydrochlorothiazide    
UPLC -MS 
2014 
0.1% formic 
Acid  in water : acetonitrile  
BEH C18 
column 
 
0.45 - 60 
Nitrendipine and 
hydrochlorothiazide 
HPLC with 
on-line 
solid-phase 
extraction 
2011 
Acetonitrile : aqueous formic 
acid 
CAPCELL MF 
C8 SPE column 
- 
237  for 
NTDP 
and 271  
for 
HCTZ 
61 
Valsartan and 
hydrochlorothiazide 
TLC 
2013 acetonitrile: water: acetic acid 
(49.35:49.35:1.3) 
- - 260 62 
 
Table 2: Validation Parameters for Chromatographic Methods 
Drugs Method Year Linearity range LOD LOQ Ref. 
Bisoprololfumarate and 
Hydrochlorothiazide  
HPLC 2008 
50–150 µg/ml (BF). 
125–375 µg/ml   (HCTZ). 
- - 29 
Olmesartanmedoxomil and 
Irbesartan and 
Hydrochlorothiazide  
HPLC 2008 
 6.25 –18 ng/ml (HCTZ). 
20–60 ng/ml (OLME). 
75-225 ng/ml 
(IRBE). 
1ng/ml (HCTZ). 2 
ng/ml (OLME). 
3 ng/ml (IRB). 
3 ng/ml (for all 
drugs). 
31 
Telmisartan and 
Hydrochlorothiazide  
HPLC 2008 
10–150 µg/ml (TELM). 
 5–75 µg/mL (HCTZ).  
0.018 µg/ml 
(TELM).0.022 µg/m 
(HCTZ). 
0.052 µg/ml 
(TELM). 
0.068 µg/ml 
(HCTZ). 
32 
Acetaminophen and 
Hydrochlorothiazide  
HPLC 2008 
0.3 to 63.8 µg/mL  (both 
drugs)  
0.169 µg/ml (AC). 
0.75  µg/ml (HCTZ). 
0.565  µg/ml 
(AC). 
2.5  µg/ml 
(HCTZ). 
33 
Hydrochlorothiazide and 
Spironolactone  
HPLC 2011 
4.0–50 µg/ML  (HCTZ). 
 5.0–50 µg/mL (SPR).   
- - 34 
Hydrochlorothiazide  LC 1992 2.0-1000     ng /ml - 2 ng/ml 35 
Angiotensin Converting Enzyme 
Inhibitors together with 
Hydrochlorothiazide  
HPLC -
UV 
2011 - 
17–64 ng/ml 
 
56–212 ng /mL 36 
Telmisartan and 
Hydrochlorothiazide  
HPLC – 
UV 
2011 
1–10 µg/ml (TELM). 
0.31– 3.12 µg/ml(HCTZ). 
0.018 µg/ml (TELM). 
0.022 µg/ml (HCTZ). 
0.052  µg/ml 
(TELM). 
0.068  µg/ml 
(HCTZ). 
37 
Zofenopril and 
Hydrochlorothiazide  
RP – LC 2011 
1.0–70.0 µg/mL (ZOF). 
 2.5–35.0 µg/mL 
(HCTZ). 
0.129 µg/ml (ZOF). 
0.183  µg/ml (HCTZ).   
0.292 µg/ml 
(ZOF). 
0.556 µg/ml 
(HCTZ). 
38 
Rosuvastatin calcium and 
Hydrochlorothiazide  
 
RP – 
HPLC 
2012 
5-30 µg/ml (ROSU). 
6.25-37.5 µg/ml (HCTZ). 
0.16 µg/ml (ROSU). 
0.20 µg/ml (HCTZ). 
0.48  µg/ml 
(ROSU). 
0.60 µg/ml 
(HCTZ). 
39 
Hydrochlorothiazide, Amlodipine, 
and Losartan  
RP – 
HPLC 
2013 
12.5-62.5 mg/ml 
(HCTZ). 
0.03 µg/ml 
(HCTZ).0.03 µg/ml 
0.1 µg/ml 
(HCTZ).0.1 
40 
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2.5-12.5 mg/ml (AMLO). 
50-250 mg/ml (LSP). 
(AMLO). 
0.108 µg/ml (LSP). 
µg/ml (AMLO). 
0.228 µg/ml 
(LOP). 
Telmisartan and 
Hydrochlorothiazide  
RP- 
HPLC 
2011 - 
0.020 µg/ml (HCTZ). 
0.010 µg/ml (TELM). 
0.060 µg/ml 
(HCTZ). 
0.031 µg/ml 
(TELM). 
41 
Bisoprololfumarate and 
Hydrochlorothiazide  
 
RP- 
HPLC 
2010 
2.5–50 µg/mL (BF). 
6.25–125 µg/mL 
(HCTZ). 
0.01 µg/ml (BF). 
0.01 µg/ml (HCTZ). 
0.03 µg/ml (BF). 
0.05 µg/ml 
(HCTZ). 
42 
Nebivolol and 
Hydrochlorothiazide  
RP- 
HPLC 
2008 - 
10 ng/ml (NEB). 
5 ng/ml (HCTZ). 
30 ng/ml (NEB). 
15 ng/ml (HCTZ). 
43 
Amlodipine besylate, Valsartan 
and Hydrochlorothiazide  
Stability 
indicating 
HPLC- 
DAD 
2013 
5–200 µg/mL  (AMLO). 
5–200  µg/mL  (VAL).         
10–200 µg/mL  (HCTZ). 
0.26 µg/ml (AMLO). 
0.24 µg/ml (VAL). 
0.12 µg/ml (HCTZ). 
0.85 µg/ml 
(AMLO). 
0.80 µg/ml 
(VAL). 
0.40 µg/ml 
(HCTZ). 
45 
OlmesartanMedoxomile, 
Amlodipine Besylate and 
Hydrochlorothiazide  
Stability 
indicating 
RP – 
HPLC 
2012 
50–150 mg/ml 
(OLME). 
12.5–37.5 mg/ml 
(AMLO). 
31–93 mg/mL (HCTZ). 
0.19 µg/ml (OLME). 
0.16 µg/ml (AMLO). 
0.22 µg/ml (HCTZ). 
0.57 µg/ml 
(OLME).0.49 
µg/ml 
(AMLO).0.66 
µg/ml (HCTZ). 
46 
 
Irbesartan and 
Hydrochlorothiazide 
Stability 
indicating 
LC 
2010 
10–200 µg/mL  (IRB).     
5–100 µg/mL (HCTZ). 
0.019 µg/ml (IRB). 
0.023 µg/ml (HCTZ). 
0.053 µg/ml 
(IRB). 
0.070 µg/ml 
(HCTZ). 
48 
Irbesartan and 
Hydrochlorothiazide  
HPTLC 2007 
100 to 700 ng/spot  
(IRB). 
100 to 350 ng/spot  
(HCTZ). 
30 ng/spot (IRB). 
25 ng/spot (HCTZ). 
100 ng/spot 
(IRB). 
100 ng/spot 
(HCTZ). 
50 
Irbesartan and 
Hydrochlorothiazide 
HPTLC 2010 
200-1000 ng/band (IRB). 
200-600 ng/band 
(HCTZ). 
30 ng/band (IEB). 
66 ng/band (HCTZ). 
100 ng/band 
(IRB). 
200 ng/band 
(HCTZ). 
52 
Bisoprolol and 
Hydrochlorothiazide  
HPLC – 
MS 
2009 
0.10–30.0 ng/mL (BF). 
1.00–80.00 ng/mL 
(HCTZ). 
0.100 ng/ml (BF). 
 1 ng/ml (HCTZ). 
0.10 ng/ml (BF). 
1 ng/ml (HCTZ). 
53 
Hydrochlorothiazide, Quinapril 
and Quinaprilat 
 
LC – MS 2008 
5–500 ng/mL (HCTZ). 
5–1500 ng/mL (QUI). 
- LLOQ 5 ng/ml 54 
Hydrochlorothiazide and 
Metoprolol 
LC – MS 2010 
3–1000 ng/mL for both 
HCTZ and MET 
- 
LLOQ for Both 
drug 3 ng/ml 
56 
Irbesartan and 
Hydrochlorothiazide  
HPLC -
MS 
2010 
0.06–6.00 µg/mL (IRB). 
1.00–112.00 ng/mL 
(HCTZ.) 
0.01 µg/ml (IRB). 
0.51  µg/ml (HCTZ). 
0.06  µg/ml 
(IRB). 
0.1 ng/ml 
(HCTZ). 
58 
Candesartan and 
Hydrochlorothiazide  
UPLC-
MS 
2014 - - 
1 ng/ml (CN). 
1 ng/ml (HCTZ) 
59 
Irbesartan  and   
Hydrochlorothiazide    
HPLC -
MS 
2014 
5–3000 ng/mL (IRB). 
0.5–300 ng/mL (HCTZ). 
- 
5 ng/ml (IRB). 
LLOQ for 0.5 
ng/ml (HCTZ). 
60 
 
 
 
Nitrendipine and 
hydrochlorothiazide 
HPLC 
with on-
line 
solid-
phase 
extraction 
2011 
5–500 ng/mL (NITR). 
And 10–1000 ng/mL 
(HCTZ). 
0.5 ng/mL (NITR).0.6 
ng/mL (HCTZ). 
- 61 
Valsartan and 
hydrochlorothiazide 
TLC 2013 
2-20. μg/spot (VAL).   1-
10 μg/spot (HCTZ) 
  0.61µg/spot (VAL).     
0.20 μg/spot (HCTZ) 
0.20 µg/spot 
(VAL).  0.066 
μg/spot (HCTZ). 
62 
 
4. Method Benefits and Limitations 
General considerations for method selection 
are discussed, focusing on important analytical 
parameters as selectivity, efficiency, sensitivity and 
robustness. The sensitivity is the most important 
method characteristic in the evaluation of the samples 
with small amount of analyte. The limit of detection 
of the most of analytical methods described in table 
3. The principal advantages of voltammetric method 
are its rapidity and simplicity. Each voltammetric run 
takes few seconds. It involves no clean up 
procedures. Capillary electrophoresis method gives 
more specificity, and accuracy. Spectrophotometry 
has always provided analytical techniques 
characterized by instrumental simplicity, moderate 
cost and portability. In these methods, fluorescence 
detection offers superior sensitivity and selectivity 
compared to that provided by UV detection. On the 
other hand, the HPLC shows advantages over 
spectrophotometric methods lies in its separation 
capability. Through chromatographic separations, the 
analytes of interest can be detected and quantified in 
the presence of degradation products and excipients. 
Additionally, capillary electrophoresis can be an 
excellent alternative separation technique to HPLC, 
however its limit of detection is usually about 50 
times poorer than that of HPLC. At present, HPLC is 
the most widely used technique for the analysis of 
bulk drugs and their formulations. However, HPLC 
methods show limitations as cost of columns, 
solvents and a lack of long-term reproducibility due 
to the proprietary nature of column packings. The 
choice of proper detection mode in HPLC analysis is 
crucial to ensure that all the components are detected. 
With UV detection, the use of this problem could be 
overcome by using a multiple wavelength scanning 
program which is capable of monitoring several 
wavelengths simultaneously. In general, fluorescence 
detection offers superior sensitivity and selectivity 
compared to that provided by UV detection. Liquid 
chromatography combined with mass spectrometry 
(LC-MS) is considered as one of the most important 
techniques of the last decade of 20th century. It 
became the method of choice for analytical support in 
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many stages of quality control and assurance within 
the pharmaceutical industry .The main advantage of 
mass spectrometric is its capability for analyzing both 
chromophoric and non-chromophoric drug 
compounds with superior selectivity and sensitivity. 
As the other techniques, this method shows some 
disadvantages as high cost, few well-defined 
analytical procedures fit in the current GMP 
requirements and variability associated with unstable 
ionization source and significant interference from 
the formulation excipients. 
 
Table 3: Comparison of sensitivity of various analytical methods 
Method Detection Sample Limit of detection Ref. 
Capillary electrophoresis UV Dosage form 0.12 mg/mL. 15 
Voltammetric method  Urine and tablet 14.0 ng ml−1(urine) 
5.0 ng ml−1 (std.) 
16 
Spectrophotometric method IR Pharmaceutical sample - 20 
UV Bulk mixture and tablet 0.91 µg/ml 21 
UV Tablet 1.0137 µg/ml 22 
UV Binary mixture 0.32 µg/ml 24 
UV Dosage form o.33 µg/ml 27 
 
 
 
 
HPLC 
UV Tablet 0.12 µg/ml 45 
UV Tablet 0.22  µg/ml 46 
UV Pharmaceutical preparation 0.023 µg/ml 48 
UV Degradation product - 49 
MS Human plasma 1 ng/ml 53 
MS Human plasma - 54 
MS Human plasma and urine - 55 
 
5. Conclusions 
The presented review provides information 
about the various methods available in the literature 
for the determination of Hydrochlorothiazide alone 
and with combination. The analysis of the published 
data revealed that the HPLC was exclusively used for 
determination of Hydrochlorothiazide. Determination 
of Hydrochlorothiazide in formulation and biological 
samples, were commend HPLC-MS/MS method, 
since this method combines the HPLC Separation 
ability with MS Sensitivity and selectivity, allowing 
the unambiguous identification of 
Hydrochlorothiazide. Sometime, HPLC with UV 
Detection is applicable because this method provides 
accurate results and low cost compared to more 
advanced detection techniques. This review carried 
out an overview of the current state-of-art analytical 
methods for determination of Hydrochlorothiazide. 
 
References 
[1] Duarte JD, Cooper-DeHof RM. Mechanisms for 
blood pressure lowering and metabolic effects of 
thiazide and thiazide-like diuretics. Expert Rev 
Cardiovasc Ther. 2010; 8: 793-802.                                              
[2] Ellison DH, Velazquez H, Wright FS. Thiazide-
sensitive sodium chloride cotransport in early 
distaltubule. Am J Physiol. 1987; 253:F546–
F554. 
[3] Bachmann S, Velazquez H, Obermuller N, Reilly 
RF, Moser D, Ellison DH. Expression of the 
thiazide-sensitive Na–Clcotransporter by rabbit 
distal convoluted tubule cells. J Clin 
Invest. 1995; 96(5):2510–2514 
[4] Obermuller N, Bernstein P, Velazquez H.  
Expression of the thiazide-sensitive Na–
Clcotransporter in rat and human kidney. Am J 
Physiol. 1995; 269:F900–F910. 
[5] Adrogue HJ, Madias NE. Sodium and potassium 
in the pathogenesis of hypertension. N Engl J 
Med.2007; 356:1966–1978. 
[6] Conway J, Lauwers P. Hemodynamic and 
hypotensive effects of long-term therapy with 
chlorothiazide. Circulation. 1960; 21:21-27.  
[7] Van Brummelen P, Man in‘t Veld AJ, 
Schalekamp MA. Hemodynamic changes during 
long-term thiazide treatment of essential 
hypertension in responders and nonresponders. 
Clin Pharmacol Ther. 1980; 27(3):328–336. 
[8] Lake CR, Ziegler MG, Coleman MD, Kopin IJ. 
Hydrochlorothiazide-induced sympathetic 
hyperactivity in hypertensive patients. Clin 
Pharmacol Ther. 1979; 26:428–432.  
[9] Wilson IM, Freis ED. Relationship between 
plasma and extracellular fluid volume depletion 
and the antihypertensive effect of chlorothiazide. 
Circulation. 1959; 20:1028–1036. 
[10] Indian Pharmacopoeia. 7th ed. Volume 2 
Ghaziabad: The Indian Pharmacopoeia 
Commission, 2014: 1900-1902. 
[11] British Pharmacopoeia. 7th ed. Volume 1, 
London: Departmanet of Health, 2007: 2982 
[12] European Pharmacopoeia. 7thed. Volume 
2,European Directorate for the Quality of 
Medicines &Health Care, 2011: 874. 
[13] Japanese Pharmacopoeia. 16th ed. The Ministry 
of Health, Labour and Welfare, 2011: 926-927. 
[14] Hillaert S, De GK, Van W. Simultaneous 
determination of Hydrochlorothiazide and 
several inhibitors of angiotensin-converting 
enzyme by capillary electrophoresis. J 
Chromatogr A.2001; 924: 439–449. 
[15] Alnajjar AO, Idris AM, Attimarad MV, 
Aldughaish AM, Elgorashe RE. Capillary 
Electrophoresis Assay Method for Metoprolol 
and Hydrochlorothiazide in their Combined 
Dosage Form with Multivariate Optimization. J 
chromatogr Sci. 2013; 51: 92–97 
http://dx.doi.org/10.1093/chromsci/bms107 
[16] Razak OQ. Electrochemical study of 
hydrochlorothiazide and its determination in 
urine and tablets. J Pharm Biomed Anal. 2004; 
34: 433–440. http://dx.doi.org/10.1016/S0731-
7085 (03)00497-7 
[17] Ferreira MH, Jez WB, Marcelo MS. 
Development and validation of a chemometric 
method for direct determination of 
hydrochlorothiazide in pharmaceutical samples 
by diffuse reflectance near infrared spectroscopy. 
Microchem J. 2012; 109: 158-164. http://dx.doi. 
Org/ 10.1016/j.microc.2012.03.008 
[18] Darwish HW, Hassan SA, Salem MY, El-Zeiny 
BA. Comparative study between derivative 
spectrophotometry and multivariate calibration 
as analytical tools applied for the simultaneous 
Review Article                                                                             Savaj Bhadresh Vet al /2015
 
 
                                                           34 
 
quantitation of Amlodipine, Valsartan and 
Hydrochlorothiazide. Spectrochim Acta part A. 
2013; 113: 215-
223.http://dx.doi.org/10.1016/j.saa.2013.04.068 
[19] Tawakkol SM, Farouk M, Elaziz OA, Hemdan 
A, Shehata MA. Comparative study between 
univariate spectrophotometry and multivariate 
calibration as analytical tools for simultaneous 
quantitation of Moexipril and 
Hydrochlorothiazide. Spectrochim Acta part A. 
2014; 133: 300-
306http://dx.doi.org/10.1016/j.saa.2014.05.061 
[20] Hacioglu F, Onal A. Determanation of 
Eprosartan Mesylate and Hydrochlorothiazide in 
Tablets by Derivative Spectrophotometric and 
High-Performance Liquid Chromatographic 
Methods. J Chromatogr Sci. 2012; 50: 688–
693.http://dx.doi.org/10.1093/chromsci/bms037 
[21] Galande VR, Baheti KG, Indraksha S, Dehghan 
MH. Estimation of Amlodipine Besylate, 
Valsartan and Hydrochlorothiazide in Bulk 
Mixture and Tablet by UV Spectrophotometry. 
Indian J Pharm Sci. 2012; 74:18-23. 
http://dx.doi.org/10.4103/0250-474X.102538 
[22] Bhatia NM, Desai RB, Jadhav SD. Simultaneous 
estimation of Losartan potassium and 
Hydrochlorothiazide from tablets by first order 
derivative Spectroscopy. Int J Pharm Pharm Sci. 
2013; 5: 464-466. 
[23] Naguib IA, Abdelaleem EA, Draz ME, Zaazaa 
HE. Linear support vector regression and partial 
least squares chemometric models for 
determination of Hydrochlorothiazide and 
Benazepril hydrochloride in presence of related 
impurities: A comparative study. Spectrochim 
Acta Part A. 2014; 130: 350–356. 
http://dx.doi.org/10.1016/j.saa.2014.04.024 
[24] Belal TS, Daabees HG, Abdel MM, Mahrous 
MS, Khamis MM. New simple 
spectrophotometric method for determination of 
the binary mixtures (atorvastatin calcium and 
ezetimibe; candesartan cilexetil and 
Hydrochlorothiazide) in tablets. J Pharm Anal. 
2013; 3:118–126. 
http://dx.doi.org/10.1016/j.jpha.2012.10.004 
[25] Ferraro CF, Castellano PM, Kaufman TS. 
Simultaneous determination of amiloride 
hydrochloride and Hydrochlorothiazide in 
synthetic samples and pharmaceutical 
formulations by multivariate analysis of 
spectrophotometric data. J Pharm Biomed Anal. 
2002; 30: 1121-1131. 
[26] El-Gindy A, Ashour A, Abdel-Fattah L, Shabana 
MM. Spectrophotometric and HPTLC-
densitometric determination of lisinopril and 
Hydrochlorothiazide in binary mixtures. J Pharm 
Biomed Anal. 2001; 25: 923–931. 
[27] Abdelwahab NS. Spectrophotometric methods 
for simultaneous determination of Carvedilol and 
Hydrochlorothiazide in combined dosage form. 
Arab J Chem. 2011 (In Press). 
[28] Rao KS, Panda M, Keshar NK. 
Spectrophotometric methods for the 
simultaneous estimation of losartan potassium 
and Hydrochlorothiazide in tablet dosage forms. 
Chronicles of Young Scientists. 2011; 2: 2-6. 
http://dx.doi.org/10.4103/2229-5186.90893 
[29] Shaikh S, Thusleem OA, Muneera MS, Akmal J, 
Kondaguli AV, Ruckmani L.A simple and rapid 
high-performance liquid chromatographic 
method for the determination of 
bisoprololfumarate and hydrochlorothiazide in a 
tablet dosage form. J Pharm Biomed Anal. 2008; 
48: 1055–1057.  
[30] Alton KV, Desrivieres D, Patrick J. High 
performance liquid chromatographic assay for 
Hydrochlorothiazide in human urine. J 
chromatogr 1986; 374: 103–110. 
[31] Najma S, Saeed AM, Shahid AS, Shahnawaz S.  
Simultaneous determination of Olmesartan 
medoxomilan Irbesartan and hydrochlorothiazide 
in pharmaceutical formulations and human 
serum using high performance liquid 
chromatography.                 Chin J Chromatogr. 
2008; 26: 544–549. 
[32] Rane VP, Sangshetti JN, Shinde DB. 
Simultaneous High-Performance Liquid 
Chromatographic Determination of Telmisartan 
and Hydrochlorothiazide in Pharmaceutical 
Preparation. J Chromatogr Sci. 2008; 46:887-
891. 
[33] Suchara EA, Carasek E. Use of Addition 
Calibration Technique for Determination of 
Acetaminophen and Hydrochlorothiazide in 
Human Urine by High-Performance Liquid 
Chromatography. J Chromatogr Sci. 2008; 
46:804-808. 
[34] Hegazy MA, Metwaly FH, Abdelkawy M, 
Abdelwahab NS. Validated Chromatographic 
Methods for Determination of 
Hydrochlorothiazide and Spironolactone in 
Pharmaceutical Formulation in Presence of 
Impurities and Degradants. J Chromatogr Sci. 
2011; 49:804-808. 
[35] Miller RB, Amestoy C. A liquid chromatographic 
method for the determination of 
hydrochlorothiazide in human plasma. J Pharm 
Biomed Anal.1992; 10: 541-545. 
[36] Elsebaei F, Zhu Y. Fast gradient high 
performance liquid chromatography method with 
UV detection for simultaneous determination of 
seven angiotensin converting enzyme inhibitors 
together with hydrochlorothiazide in 
pharmaceutical dosage forms and spiked human 
plasma and urine. Talanta. 2011; 85: 123–
129.http://dx.doi.org/10.1016/j.talanta.2011.03.0
37 
[37] Salama I. Simultaneous HPLC–UV analysis of 
Telmisartan and Hydrochlorothiazide in human 
plasma. Bulletin of Faculty of Pharmacy, Cairo 
University 2011; 11:19–24                                                                                                                             
[38]  Aslan SS. Validated RP-HPLC method for 
simultaneous Determination of Zofenopril and 
Hydrochlorothiazide in Pharmaceutical 
Preparations. J Chromatogr Sci. 2011; 49: 259-
263. 
[39] Sheth A, Patel KN, Ramlingam B, Shah N.                                                                                                                                     
Simultaneous estimation of rosuvastatin calcium 
and Hydrochlorothiazide from bulk and 
commercial products using a validated reverse 
phase high performance liquid chromatographic 
technique. Scholars Research Journal. 2012; 
2:7-11. 
[40] Tengli AR, Gurupadayya BM, Soni N.                                                                                                                                                      
Simultaneous estimation of hydrochlorothiazide, 
amlodipine, and losartan in tablet dosage form 
by RP-HPLC. Int j chemand anal sci. 2013; 4: 
33-38.  
[41] Mukhopadhyay S, Kadam K, Sawant L, Nachane 
D, Pandita N. Simultaneous determination of 
related substances of Telmisartan and 
Hydrochlorothiazide in tablet dosage form by 
using reversed phase high performance liquid 
chromatographic method. J Pharm and Bioa Sci. 
2011; 3:375-383.http://dx.doi.org/10.4103/0975-
7406.84441 
[42] Joshi SJ, Karbhari PA, Bhoir SI, Bindu KS, Das 
C.RP-HPLC method for simultaneous estimation 
of Bisoprololfumarate and hydrochlorothiazide 
in tablet formulation. J Pharm Biomed Anal. 
2010; 52: 362–371.http://dx.doi.org/ 
10.1016/j.jpba.2009.10.021 
Review Article                                                                             Savaj Bhadresh Vet al /2015
 
 
                                                           35 
 
[43] Meyyanathan SN, Rajan S, Muralidharan S, 
Arunadevi S. Birajdar, Suresh B. A Validated 
RP-HPLC Method for Simultaneous Estimation 
of Nebivololand Hydrochlorothiazide in Tablets. 
Indian J. Pharm. 2008; 687-689: 70; 687-
689.http://dx.doi. .org/ 10.4103/0250-474X.4542 
[44] Rawoola ND, Venkatchalam A. Analytical 
Method for the Simultaneous Estimation of 
Hydrochlorothiazide and Metoprolol Tartrate 
using RP HPLC. Indian J. Pharm. 2011; 73; 219-
223.http://dx.doi.org/ 10.4103/0250-474X.91565 
[45] Shaalan RA, Belal TS, El YF, Elonsy SM. 
Validated stability-indicating HPLC-DAD 
method of analysis for the antihypertensive triple 
mixture of amlodipine besylate, valsartan and 
Hydrochlorothiazide in their tablets. Arab J 
Chem 2013 (In Press).  
[46] Jain PS, Patel MK, Gorle AP, Chaudhari AJ, 
Surana SJ. Stability-Indicating Method for 
Simultaneous Estimation of Olmesartan 
Medoxomile, Amlodipine Besylate and 
Hydrochlorothiazide by RP-HPLC in Tablet 
Dosage Form. J Chromatogr Sci. 2012; 50: 680–
687.http://dx.doi.org/10.1093/chromsci/bms067 
[47] Lusina M, Cindri T, Tomai J, Peko M, Pozai L, 
Musulin N. Stability study of 
losartan/Hydrochlorothiazide tablets. Int J 
Pharm. 2005; 291: 127–
137.http://dx.doi.org/10.1016/j.ijpharm.2004.07.
050 
[48] Rane VP, Patil KR, Sangshetti JN, Yeole RD, 
Shinde DB.  Stability Indicating LC Method for 
Simultaneous Determination of Irbesartan and 
Hydrochlorothiazide in Pharmaceutical 
Preparations. J Chromatogr Sci. 2010; 48:595-
600. 
[49] Hertzog DL, McCafferty JF, Fang X, Tyrrell RJ, 
Reed RA. Development and validation of a 
stability-indicating HPLC method for the 
simultaneous determination of Losartan 
potassium, Hydrochlorothiazide, and their 
degradation products. J Pharm Biomed Anal. 
2002; 32: 747–760. 
[50] Shah NJ, Suhagia BN, Shah RR, Patel NM. 
Development and validation of a HPTLC method 
for simultaneous estimation of Irbesartan and 
Hydrochlorothiazide in tablet dosage form. 
Indian J Pharm Sci.  2007; 69: 240-
243.http://dx.doi.org/10.4103/0250-474x.33150 
[51] El-Gindy A, Ashour A, Abdel-Fattah L, Shabana 
MM. Spectrophotometric and HPTLC-
densitometric determination of lisinopril and 
Hydrochlorothiazide in binary mixtures. J Pharm 
Biomed Anal.2001; 25:923–931. 
[52] Khodke AS, Potale LV, Damle MC, Bothara KG. 
A validated stability indicating HPTLC method 
for simultaneous estimation of irbesartan and 
hydrochlorothiazide. Pharmaceutical Methods. 
2010; 2: 39-43.  
[53] Tutunji MF, Ibrahim HM, Khabbas MH, Tutunji 
LF. Simultaneous determination of bisoprolol 
and hydrochlorothiazide in human plasma by 
HPLC coupled with tandem mass spectrometry. J 
Chromatogr B. 2009; 877: 1689–1697. 
http://dx.doi.org/10.1016/j.jchromb.2009.04.021 
[54] Parekh SA, Pudage A, Joshi SS, Vaidya VV, 
Gomes NA, Kamat SS. Simultaneous 
determination of hydrochlorothiazide, quinapril 
and quinaprilat in human plasma by liquid 
chromatography-tandem mass spectrometry. J 
Chromatogr B. 2008; 873: 59–69. 
http://dx.doi.org/10.1016/j.jchromb.2008.07.046 
[55] Liu D, Jiang J, Wang P, Feng S,  Hu P.  
Simultaneous quantitative determination of 
olmesartan and hydrochlorothiazide in human 
plasma and urine by liquid chromatography 
coupled to tandem mass spectrometry. J 
Chromatogr B. 2010; 878: 743–
748.http://dx.doi.org/10.1016/j.jchromb.2010.01.
009 
[56] Gao F,  Zhang M, Cui X, Wang Z, Sun Y, Gu J. 
Simultaneous quantitation of 
Hydrochlorothiazide and metoprolol in human 
plasma by liquid chromatography–tandem mass 
spectrometry. J Pharm Biomed Anal. 2010; 52: 
149–154.  
[57] Gadepalli SG, Deme P, Kuncha M, Sistla R. 
Simultaneous determination of amlodipine, 
valsartan and hydrochlorothiazide by LC–ESI-
MS/MS and its application to pharmacokinetics 
in rats. J Pharm Anal. (In Press). 
http://dx.doi.org/10.1016/j.jpha.2013.12.003 
[58] Tutunji LF, Tutunji MF, Alzoubi MI, Khabbas 
MH, Arida AI. Simultaneous determination of 
irbesartan and hydrochlorothiazide in human 
plasma using HPLC coupled with tandem mass 
spectrometry: Application to bioequivalence 
studies. J Pharm Biomed Anal. 2010; 51: 985–
990.  
[59] Singh B, Lokhandae RS, Dwivedi A, Sharma S, 
Dubey N. Improved simultaneous quantitation of 
candesartan and hydrochlorothiazide in human 
plasma by UPLC–MS/MS and its application in 
bioequivalence studies. J Pharm Anal. 2014; 
4:144–152. 
http://dx.doi.org/10.1016/j.jpha.2013.05.003 
[60] Qiu X, Wang Z, Wang B, Zhan H, Pan X, Xu R. 
Simultaneous determination of irbesartanan 
dhydrochlorothiazide in human plasma byultra-
high performance liquid chromatography tandem 
mass spectrometry and its application to a 
bioequivalence study. J Chromatogr B. 2014; 
957: 110–115.http://dx.doi. 
org/10.1016/j.jchromb.2014.03.002 
[61] Shang D, Wang X, Zhao X, Huang F, Tian G, 
Lua W, Zhou T. Simultaneous determination of 
nitrendipine and hydrochlorothiazide in 
spontaneously hypertensive rat plasma using 
HPLC with on-line solid-phase extraction. J 
Chromatogr B. 2011; 879: 3459-
3464.http://dx.doi.org/10.1016/j.jchromb.2011.0
9.025. 
[62] Ramadan AZ, Al-Akraa H, Maktabi M. TLC 
simultaneous determination of valsartan and 
hydrochlorothiazide in pure form and in tablets 
using butyl-modified Aleppobentonite. Int J 
Pharm Pharm Sci. 2013; 5: 762-76. 
 
